➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Express Scripts
AstraZeneca
Moodys
McKesson

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

CETIRIZINE HYDROCHLORIDE HIVES RELIEF Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Cetirizine Hydrochloride Hives Relief, and what generic alternatives are available?

Cetirizine Hydrochloride Hives Relief is a drug marketed by Aurobindo Pharma Ltd, Bionpharma Inc, Sun Pharm Inds Inc, Amneal Pharms Ny, Taro, and Torrent Pharms Llc. and is included in seven NDAs.

The generic ingredient in CETIRIZINE HYDROCHLORIDE HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and thirty-three suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Cetirizine Hydrochloride Hives Relief

A generic version of CETIRIZINE HYDROCHLORIDE HIVES RELIEF was approved as cetirizine hydrochloride by TEVA PHARMS on May 27th, 2008.

  Start Trial

Summary for CETIRIZINE HYDROCHLORIDE HIVES RELIEF
Drug patent expirations by year for CETIRIZINE HYDROCHLORIDE HIVES RELIEF
Recent Clinical Trials for CETIRIZINE HYDROCHLORIDE HIVES RELIEF

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 4
JDP Therapeutics, Inc.Phase 2
Ciusss de L'Est de l'Île de MontréalPhase 3

See all CETIRIZINE HYDROCHLORIDE HIVES RELIEF clinical trials

US Patents and Regulatory Information for CETIRIZINE HYDROCHLORIDE HIVES RELIEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride CAPSULE;ORAL 209107-002 Jul 20, 2018 OTC No No   Start Trial   Start Trial   Start Trial
Amneal Pharms Ny CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride TABLET;ORAL 078780-002 Jan 21, 2010 OTC No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Inc CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride TABLET, CHEWABLE;ORAL 077631-001 Jan 11, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Torrent Pharms Llc CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride TABLET;ORAL 079191-003 Apr 15, 2010 OTC No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Medtronic
Express Scripts
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.